Jack He, MD, MSc, RAc Canadian Integrative Cancer Therapies Association Cancer cachexia is a manifestation that results in malnutrition in patients and causes poor quality of life and affect chances of survival due to loss of weight, muscle atrophy, fatigue, weakness, and significant loss of appetite. Some factors that resultContinue Reading
Jack He MD, MSc, RAc Canadian Integrative Cancer Therapies Association Why human beings are losers in fighting against cancer? Why the current anticancer drugs have little therapeutic effect? We believe that the main reason could be related to several factors, such as the genetic instability and non-homogeneity of tumor cells,Continue Reading
Dr. Jack He, MD, MSc, RAc Traditional Chinese medicine (TCM) was originated thousands of years ago through its meticulous observation and empirical working on healing theories and practices. With respect to cancer therapy, the philosophy of TCM proposes the concept of modulation and balance to restore and enhance the resistanceContinue Reading
Dr. Jack He MD, MSc, RAc NICT therapy is an integrative remedy developed and constantly improved through long term clinical observation for late-stage multi-drug resistant cancers. This therapy incorporates modern medical science with various up-to-date alternative cancer care concepts such as Traditional Chinese Medicine and the naturopathic therapies. NICT therapyContinue Reading
Dr. Jack He, MD, MSc, RAc To date, cancer treatment regimen is most likely to be a combination of standardization and individualization. It is about integrating individual clinical expertise and the best external evidence. Thereby oncologists can improve the treatment of cancer by integration of evidence-based medicine and customized cancerContinue Reading
Dr. Jack He, MD, MSc, RAc The medical modality of Integrative Medicine (or Integrated Medicine as it is referred to in the United Kingdom) has been proposed formally at the 51st WHO World Health Assembly in 1998 and been regarded as “the new medical perspectives in the 21st century”. AtContinue Reading
Asia Pacific Foundation of Canada Stories of Immigrated Chinese Entrepreneurs in Canada chineseentbooklet_final_reduced_2.pdf (asiapacific.ca) By Yingqiu Kuang In a two-story office building in Burnaby, British Columbia, Jack He and his team are hard at work. They are busy finalizing the marketing strategy of their newly finished skincare product line, organizingContinue Reading
贺福长, 李德伦, 毛天球 摘要 采用噻唑兰 (MTT) 方法观察 0.25T 的恒定强磁场对 4 种口腔颌面部癌细胞体外培养的影响. 发现磁场对这 4 种癌细胞均有不同程度的抑制作用, 其中腺癌细胞比鳞癌细胞对磁场更为敏感, 并且随着磁场作用时间加长, 这种抑制作用更明显. 平阳霉素对体外培养的人粘液表皮样癌 MEC-1系细胞生长有较强的抑制作用, 而与 0.25T 恒定强磁场联合应用后, 抑制作用明显增强, 两者有相加用. 关键词: 磁场; 癌; 平阳霉素 我们观察了 0.25T 恒定强磁场以及其联合平阳霉素对人口腔颌面部 4 种癌细胞体外培养的影响, 报道如下. 材料和方法 癌细胞系采用第四军医大学口腔医学院中心实验室建立的传代细胞系即人粘液表皮样癌 MEC-1系, 腺样囊性癌 SACC-83 系, 舌癌 Tca8113 系, 牙齦癌 Ca9-22 系; 平阳霉素为天津市河北制药总厂出品; 磁场由 N, SContinue Reading
第四军医大学口腔医学院领面外科 – 贺福长, 毛天球, 李德伦, 吴军正, 贾宝军 西北上业大学 – 邹光荣, 唐卫, 姜战军 〔摘要〕 利用稀土永磁体磁片形成 0.25T 的恒定强磁场, 观察该强度磁场对四种口腔颌面部癌细胞体外培养的影响, 发现对这四种癌细胞均有不同程度抑制作用, 其中两种腺癌细胞比两种鳞癌细胞对磁场更敏感些, 并发现随着磁场作用时间加长, 这种抑制作用更明显. 磁性脂质体被体外培养的癌细胞摄取后将会增强这种抑制作用. 关键词: 磁生物效应; 脂质体; 恒定强磁场; 癌 近年来, 生物磁学的基础研究和应用研究发展迅速, 其中磁场对细胞尤其是肿瘤细胞的生物效应研究尤引人注目, 但目前为止对人的肿瘤细胞研究很少, 对人口腔颌面部恶性肿瘤细胞的研究目前尚未见有报道. 本文拟通过对 0.25T 恒定强磁场对人口腔颌面部四种癌细胞体外培养的影响观察, 希望对恶性肿瘤磁疗学提供有益的参考资料. 1 材料与方法 1.1 癌细胞系采用本院中心实验室建立的传代细胞系即人粘液表皮样癌 MEC-1 系, 腺样囊性癌 SACC-83 系, 舌癌 Tca8113 系及牙齦癌 Ca9-22 系.Continue Reading
贺福长 李德伦 毛天球 沈阳军区总医院口腔科110015 2 第四军医大学口腔医学院 摘要 以荷人粘液表皮样癌的裸鼠作为动物模型, 采用局部给药方式, 同时在肿瘤部位放置 0.23T 恒定强磁场对肿瘤进行磁导向化疗. 实验结果显示, 平阳霉素磁性脂质体对人粘液表皮样癌的移植瘤有显著抑制作用, 抑瘤率为 81.1%, 显著高于平霉素脂质体 (60.9%) 和游离平阳霉素 (45.5%), 而且其对正常组织 (主要是肺脏) 的毒副作用明显减轻. 关键词: 磁场; 磁性脂质体; 癌; 治疗 磁性脂质体是磁导向药物传递系统中一种新型的药物导向载体. 其制备过程为物理过程, 制成的抗癌药物磁性脂质体能包裹 103～104 个药物分子和 Fe3O4 分子, 因而同时具备脂质体与磁导向药物化疗的优点, 为肿瘤导向治疗提供新的手段. 目前磁性脂质体应用于导向治疗肿瘤的有关研究国内外均处于起步阶段. 本实验拟通过对研制的平阳霉素磁性脂质体对人粘液表皮样癌体内抗肿瘤作用观察, 以评价其作为导向治疗肿瘤的新型载体的可行性, 为今后进一步深入研究提供实验依据. 1 材料与方法 1. 1 人粘液表皮样癌 MEC-1 系为第四军医大学口腔医学院口腔生物学教研室提供; BALB/C-nu/nu 系健康裸小鼠 20 只,Continue Reading